Inhalation Anesthetics Market, By Type (Desflurane, Sevoflurane, Isoflurane, and Other Types), By End-User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and So

Inhalation Anesthetics Market, By Type (Desflurane, Sevoflurane, Isoflurane, and Other Types), By End-User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Inhalation anesthetics (such as isoflurane, desflurane, nitrous oxide, sevoflurane, halothane, most commonly used agents in practice today) are widely used for induction and maintenance of general anesthesia in the operating room. Inhalational anesthetic is the chemical compound possessing general anesthetic properties that can be delivered via inhalation. These anesthetics are used for both the induction & maintenance of general anesthesia during surgery. Inhalation anesthetics produce sedation on a spectrum up to and including general anesthesia as well as other clinical effects.

Market Dynamics:

Increasing number of emergency cases and surgical interventions, rise in geriatric population prone to chronic diseases, growing demand for lesser duration in hospitalization, and increasing accessibility to health services and surgeries are some major factors expected to augment the growth of the global inhalation anesthetics market. Most chronic illnesses do not fix themselves and are generally not cured completely, and thus, require surgery. One in four surgical patients has a chronic disease with an associated 10-fold increase in risk of postoperative death. Thus, with the increasing number of surgeries, the usage of inhalation anesthetics is also increasing with a rapid pace worldwide.

In April 2020, Blue-Zone Technologies Ltd. announced receipt from Health Canada of a Drug Identification Number (DIN) for DESFLURANE, USP, a drug used for general anesthesia. The DIN permits Blue-Zone to both produce and commercially launch its branded generic drug.

Moreover, in January 2022, Dechra Pharmaceuticals announced the acquisition of Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences. The 2 inhalation anesthesia solutions are used in both human and animal medicine. Dechra plans to launch veterinary branded Isoflurane and Sevoflurane products this year.

Key features of the study:

• This report provides in-depth analysis of the global inhalation anesthetics market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global inhalation anesthetics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AbbVie Inc., Baxter, Merck KgaA, Trokiaa, Piramal Enterprises Ltd., Lunan Pharmaceutical Group Co. Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi AG (Fresenius SE& Co. KGaA), Jiangsu Hengrui Medicine Co. Ltd., and Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global inhalation anesthetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthetics market.

• Global Inhalation Anesthetics Market, By Type:
• Desflurane
• Sevoflurane
• Isoflurane
• Other Types
• Global Inhalation Anesthetics Market, By End-User:
• Hospitals
• Ambulatory Surgical Centers
• Other End Users
• Global Inhalation Anesthetics Market, By Geography:
• North America
• Europe
• Asia-Pacific
• Middle East
• Africa
• South America
• Company Profiles:
• AbbVie Inc.
• Baxter
• Merck KgaA
• Trokiaa
• Piramal Enterprises Ltd.
• Lunan Pharmaceutical Group Co. Ltd.
• Hikma Pharmaceuticals PLC
• Fresenius Kabi AG (Fresenius SE& Co. KGaA)
• Jiangsu Hengrui Medicine Co. Ltd.
• Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)